Click here to close.Click here to view disclaimer.
Share this page from the NHLBI on Blogger.
Share this page from the NHLBI on Buzz.
Share this page from the NHLBI on Delicious.
Share this page from the NHLBI on Digg.
Share this page from the NHLBI on Facebook.
Add this link to the NHLBI to my browser.
Email this page with Gmail.
Bookmark this page with Google.
Share this page from the NHLBI on LinkedIn.
Share this page from the NHLBI on Messenger.
Share this page from the NHLBI on MySpace.
Share this page from
the NHLBI on Reddit.
Share this page from the NHLBI on Stumble.
Share this page from the NHLBI on Tumblr.
Share this page from the NHLBI on Twitter.
Who Is at Risk for Raynaud's?
The risk factors for primary Raynaud's (Raynaud's disease) and secondary Raynaud's (Raynaud's phenomenon) are different.
The risk factors for primary Raynaud's include:
Gender. Women are more likely to have primary Raynaud's than men.
Age. Primary Raynaud's usually develops before the age of 30.
Family history. Primary Raynaud's may occur in members of the same family.
Living in a cold climate. Cold temperatures can trigger Raynaud's attacks.
The risk factors for secondary Raynaud's include:
Age. Secondary Raynaud's usually develops after the age of 30.
Certain diseases and conditions. For example, diseases that directly damage the arteries or damage the nerves that control the arteries in the hands and feet may cause secondary Raynaud's. (For more information, go to "What Causes Raynaud's?")
Injuries to the hands or feet.
Exposure to certain workplace chemicals, such as vinyl chloride (used in the plastics industry).
Repetitive actions with the hands, such as typing or using vibrating tools.
Certain medicines, such as migraine, cancer, cold/allergy, or blood pressure medicines.
Smoking.
Living in a cold climate.
WAS THIS HELPFUL?
Your rating was 1 star(s)
Your rating was 2 star(s)
Your rating was 3 star(s)
Your rating was 4 star(s)
Raynaud's Clinical Trials
Clinical trials are research studies that explore whether a medical strategy, treatment, or device is safe and effective for humans. To find clinical trials that are currently underway for Raynaud's, visit www.clinicaltrials.gov.
February 01, 2011
The NHLBI updates Health Topics articles on a biennial cycle based on a thorough review of research findings and new literature. The articles also are updated as needed if important new research is published. The date on each Health Topics article reflects when the content was originally posted or last revised.